Thermo Fisher Scientific (NYSE:TMO) announced a quarterly dividend on Thursday, May 24th, RTT News reports. Investors of record on Friday, June 15th will be given a dividend of 0.17 per share by the medical research company on Monday, July 16th. This represents a $0.68 dividend on an annualized basis and a yield of 0.31%. The ex-dividend date of this dividend is Thursday, June 14th.
Thermo Fisher Scientific has a payout ratio of 6.4% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Thermo Fisher Scientific to earn $12.13 per share next year, which means the company should continue to be able to cover its $0.60 annual dividend with an expected future payout ratio of 4.9%.
TMO stock opened at $215.97 on Friday. Thermo Fisher Scientific has a twelve month low of $170.07 and a twelve month high of $226.44. The stock has a market cap of $87.11 billion, a P/E ratio of 22.76, a PEG ratio of 1.59 and a beta of 1.14. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.95 and a current ratio of 1.36.
Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, April 25th. The medical research company reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.42 by $0.08. Thermo Fisher Scientific had a return on equity of 16.09% and a net margin of 10.24%. The business had revenue of $5.85 billion for the quarter, compared to the consensus estimate of $5.62 billion. During the same period last year, the business earned $2.08 earnings per share. The firm’s revenue for the quarter was up 22.8% compared to the same quarter last year. sell-side analysts predict that Thermo Fisher Scientific will post 10.9 earnings per share for the current fiscal year.
A number of equities research analysts recently weighed in on the company. Zacks Investment Research downgraded Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Wednesday, May 16th. Morgan Stanley lifted their target price on Thermo Fisher Scientific from $216.00 to $230.00 and gave the stock an “overweight” rating in a research report on Thursday, April 26th. Barclays lifted their target price on Thermo Fisher Scientific from $225.00 to $245.00 and gave the stock an “overweight” rating in a research report on Thursday, February 1st. Leerink Swann reissued an “outperform” rating and set a $239.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a research report on Thursday, February 1st. They noted that the move was a valuation call. Finally, Bank of America raised their price target on shares of Thermo Fisher Scientific from $235.00 to $250.00 and gave the stock a “buy” rating in a research note on Thursday, February 1st. One analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company. Thermo Fisher Scientific has an average rating of “Buy” and a consensus price target of $224.38.
In other news, Director C Martin Harris sold 206 shares of Thermo Fisher Scientific stock in a transaction that occurred on Friday, May 18th. The shares were sold at an average price of $214.43, for a total value of $44,172.58. Following the completion of the transaction, the director now owns 5,106 shares in the company, valued at $1,094,879.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Stephen Williamson sold 2,500 shares of Thermo Fisher Scientific stock in a transaction that occurred on Monday, March 5th. The shares were sold at an average price of $204.60, for a total transaction of $511,500.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 42,706 shares of company stock valued at $8,962,073. Corporate insiders own 0.49% of the company’s stock.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.